Effects of interferon-alpha on serum hepatitis C virus in patients with chronic hepatitis C.
Interferon is beneficial in some patients with chronic hepatitis C. To assess the efficacy of interferon, we used the polymerase chain reaction (PCR) to measure HCV RNA in serial serum samples from 13 chronic hepatitis C patients who were treated with interferon-alpha. Serum alanine aminotransferase (ALT) values normalized in association with the disappearance of serum HCV RNA in nine cases during the therapy. Serum HCV remained negative after the therapy in the three patients who had no relapse, while serum HCV RNA reappeared in the six patients with elevation of ALT values. The persistence of normal ALT levels appears to be correlated with the clearance of the serum HCV. There were two patients whose ALT became normal immediately after the cessation of interferon. Serum HCV was detectable at the end of treatment when serum ALT was elevated, and thereafter serum HCV disappeared. This result suggests an immunomodulatory effect of interferon in the clearance of HCV in some cases. Furthermore, the semiquantitative PCR assay showed that all five patients in whom ALT values were normal at the end of follow-up without detectable serum HCV genome had lower HCV titers in the pretreatment sera than the other eight patients. The detection of HCV RNA by the PCR assay is useful in determining the efficacy of interferon and its mechanisms.
Shibata
M
M
Department of Pediatrics, Nagoya University School of Medicine, Japan.
Kumada
T
T
Yamada
M
M
Nakano
S
S
Kudo
T
T
Morishima
T
T
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D015139:Blotting, Southern; D002908:Chronic Disease; D004247:DNA / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods; D012008:Recurrence; D013997:Time Factors
D004279:DNA, Viral; D016898:Interferon-alpha; D004247:DNA; D000410:Alanine Transaminase